{"transactions":[{"id":1217048,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2025-03-07T16:14:26.000Z","date":"2025-03-05","kind":"exercise","planned":false,"acquired":false,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest as to 1/4th of the total shares annually beginning on March 5, 2022, subject to continued service through each vesting date."}],"balance_after":0,"derivative":{"expiration_date":"2025-03-05","underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001415889-25-007405","document":"form4-03072025_090322.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000141588925007405/form4-03072025_090322.xml","form_type":"4"}},{"id":1217047,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-03-07T16:14:26.000Z","date":"2025-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":6708,"price":1.36,"value":9122.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person."}],"balance_after":292531,"source":{"system":"sec-edgar","filing":"0001415889-25-007405","document":"form4-03072025_090322.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000141588925007405/form4-03072025_090322.xml","form_type":"4"}},{"id":1217046,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-03-07T16:14:26.000Z","date":"2025-03-05","kind":"exercise","planned":false,"acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":299239,"source":{"system":"sec-edgar","filing":"0001415889-25-007405","document":"form4-03072025_090322.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000141588925007405/form4-03072025_090322.xml","form_type":"4"}},{"id":1219249,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2025-03-06T16:09:29.000Z","date":"2025-03-04","kind":"exercise","planned":false,"acquired":false,"shares":31125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest as to 1/4th of the total shares annually beginning on March 4, 2023, subject to continued service through each vesting date."}],"balance_after":31125,"derivative":{"expiration_date":"2026-03-04","underlying":"Common Stock","underlying_shares":31125},"source":{"system":"sec-edgar","filing":"0001415889-25-007183","document":"form4-03062025_090325.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000141588925007183/form4-03062025_090325.xml","form_type":"4"}},{"id":1219248,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-03-06T16:09:29.000Z","date":"2025-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":11136,"price":1.42,"value":15813.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person."}],"balance_after":280489,"source":{"system":"sec-edgar","filing":"0001415889-25-007183","document":"form4-03062025_090325.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000141588925007183/form4-03062025_090325.xml","form_type":"4"}},{"id":1219247,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-03-06T16:09:29.000Z","date":"2025-03-04","kind":"exercise","planned":false,"acquired":true,"shares":31125,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":291625,"source":{"system":"sec-edgar","filing":"0001415889-25-007183","document":"form4-03062025_090325.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000141588925007183/form4-03062025_090325.xml","form_type":"4"}},{"id":1227238,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2025-03-04T18:32:10.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":false,"shares":41750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest as to 1/4th of the total award annually beginning on March 1, 2025, subject to continued service through each vesting date."}],"balance_after":125250,"derivative":{"expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":41750},"source":{"system":"sec-edgar","filing":"0001415889-25-006690","document":"form4-03042025_110305.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000141588925006690/form4-03042025_110305.xml","form_type":"4"}},{"id":1227237,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2025-03-04T18:32:10.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":false,"shares":23750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest as to 1/4th of the total shares annually beginning on March 1, 2024, subject to continued service through each vesting date."}],"balance_after":47500,"derivative":{"expiration_date":"2027-03-01","underlying":"Common Stock","underlying_shares":23750},"source":{"system":"sec-edgar","filing":"0001415889-25-006690","document":"form4-03042025_110305.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000141588925006690/form4-03042025_110305.xml","form_type":"4"}},{"id":1227236,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-03-04T18:32:10.000Z","date":"2025-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":25203,"price":1.59,"value":40072.77,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person."}],"balance_after":260500,"source":{"system":"sec-edgar","filing":"0001415889-25-006690","document":"form4-03042025_110305.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000141588925006690/form4-03042025_110305.xml","form_type":"4"}},{"id":1227235,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-03-04T18:32:10.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":true,"shares":41750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":285703,"source":{"system":"sec-edgar","filing":"0001415889-25-006690","document":"form4-03042025_110305.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000141588925006690/form4-03042025_110305.xml","form_type":"4"}},{"id":1227234,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-03-04T18:32:10.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":true,"shares":23750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":243953,"source":{"system":"sec-edgar","filing":"0001415889-25-006690","document":"form4-03042025_110305.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000141588925006690/form4-03042025_110305.xml","form_type":"4"}},{"id":1563195,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units (RSUs)","published_at":"2024-03-22T16:28:42.000Z","date":"2024-03-05","kind":"grant","planned":false,"acquired":true,"shares":167000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest as to 1/4th of the total award annually beginning on March 1, 2025, subject to continued service through each vesting date."}],"balance_after":167000,"derivative":{"expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":167000},"source":{"system":"sec-edgar","filing":"0001415889-24-008954","document":"form4a-03222024_080335.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000141588924008954/form4a-03222024_080335.xml","form_type":"4/A","original_submission_date":"2024-03-07"}},{"id":1588847,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2024-03-07T16:31:10.000Z","date":"2024-03-05","kind":"exercise","planned":false,"acquired":false,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vest as to 1/4th of the total award annually beginning on March 5, 2022, subject to continued service through each vesting date."}],"balance_after":18750,"derivative":{"expiration_date":"2025-03-05","underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001415889-24-007188","document":"form4-03072024_090300.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000141588924007188/form4-03072024_090300.xml","form_type":"4"}},{"id":1588846,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units (RSUs)","published_at":"2024-03-07T16:31:10.000Z","date":"2024-03-05","kind":"grant","planned":false,"acquired":true,"shares":130500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest as to 1/4th of the total award annually beginning on March 1, 2025, subject to continued service through each vesting date."}],"balance_after":130500,"derivative":{"expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":130500},"source":{"system":"sec-edgar","filing":"0001415889-24-007188","document":"form4-03072024_090300.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000141588924007188/form4-03072024_090300.xml","form_type":"4"}},{"id":1588845,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2024-03-07T16:31:10.000Z","date":"2024-03-05","kind":"grant","planned":false,"acquired":true,"shares":174000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests as to 2.0833% of the total award monthly, beginning on April 1, 2024, with 100% of the award being vested and exercisable on March 1, 2028, subject to the reporting person's continued service to the Issuer on each vesting date."}],"balance_after":174000,"derivative":{"exercise_price":4.54,"expiration_date":"2034-03-05","underlying":"Common Stock","underlying_shares":174000},"source":{"system":"sec-edgar","filing":"0001415889-24-007188","document":"form4-03072024_090300.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000141588924007188/form4-03072024_090300.xml","form_type":"4"}},{"id":1588844,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-03-07T16:31:10.000Z","date":"2024-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":6690,"price":4.54,"value":30372.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person."}],"balance_after":220203,"source":{"system":"sec-edgar","filing":"0001415889-24-007188","document":"form4-03072024_090300.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000141588924007188/form4-03072024_090300.xml","form_type":"4"}},{"id":1588843,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-03-07T16:31:10.000Z","date":"2024-03-05","kind":"exercise","planned":false,"acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":226893,"source":{"system":"sec-edgar","filing":"0001415889-24-007188","document":"form4-03072024_090300.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000141588924007188/form4-03072024_090300.xml","form_type":"4"}},{"id":1591050,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2024-03-06T16:28:16.000Z","date":"2024-03-04","kind":"exercise","planned":false,"acquired":false,"shares":31125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest as to 1/4th of the total award annually beginning on March 4, 2023, subject to continued service through each vesting date."}],"balance_after":62250,"derivative":{"expiration_date":"2026-03-04","underlying":"Common Stock","underlying_shares":31125},"source":{"system":"sec-edgar","filing":"0001415889-24-007039","document":"form4-03062024_090306.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000141588924007039/form4-03062024_090306.xml","form_type":"4"}},{"id":1591049,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-03-06T16:28:16.000Z","date":"2024-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":11105,"price":4.79,"value":53192.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person."}],"balance_after":208143,"source":{"system":"sec-edgar","filing":"0001415889-24-007039","document":"form4-03062024_090306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000141588924007039/form4-03062024_090306.xml","form_type":"4"}},{"id":1591048,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-03-06T16:28:16.000Z","date":"2024-03-04","kind":"exercise","planned":false,"acquired":true,"shares":31125,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":219248,"source":{"system":"sec-edgar","filing":"0001415889-24-007039","document":"form4-03062024_090306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000141588924007039/form4-03062024_090306.xml","form_type":"4"}},{"id":1594906,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2024-03-05T16:40:24.000Z","date":"2024-03-01","kind":"exercise","planned":false,"acquired":false,"shares":23750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSU award vests as to 1/4th of the total award annually beginning on March 1, 2024, subject to continued service through each vesting date."}],"balance_after":71250,"derivative":{"expiration_date":"2027-03-01","underlying":"Common Stock","underlying_shares":23750},"source":{"system":"sec-edgar","filing":"0001415889-24-006725","document":"form4-03052024_090358.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000141588924006725/form4-03052024_090358.xml","form_type":"4"}},{"id":1594905,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-03-05T16:40:24.000Z","date":"2024-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":8559,"price":4.95,"value":42367.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person."}],"balance_after":188123,"source":{"system":"sec-edgar","filing":"0001415889-24-006725","document":"form4-03052024_090358.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000141588924006725/form4-03052024_090358.xml","form_type":"4"}},{"id":1594904,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-03-05T16:40:24.000Z","date":"2024-03-01","kind":"exercise","planned":false,"acquired":true,"shares":23750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":196682,"source":{"system":"sec-edgar","filing":"0001415889-24-006725","document":"form4-03052024_090358.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000141588924006725/form4-03052024_090358.xml","form_type":"4"}},{"id":1664967,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2024-01-31T16:29:30.000Z","date":"2024-01-29","kind":"exercise","planned":false,"acquired":false,"shares":13750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest as to 1/4th of the total shares annually beginning on January 29, 2021, subject to continued service through each vesting date."}],"balance_after":0,"derivative":{"expiration_date":"2024-01-29","underlying":"Common Stock","underlying_shares":13750},"source":{"system":"sec-edgar","filing":"0001415889-24-002072","document":"form4-01312024_090125.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000141588924002072/form4-01312024_090125.xml","form_type":"4"}},{"id":1664966,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-01-31T16:29:30.000Z","date":"2024-01-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":5634,"price":4.99,"value":28113.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person."}],"balance_after":172932,"source":{"system":"sec-edgar","filing":"0001415889-24-002072","document":"form4-01312024_090125.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000141588924002072/form4-01312024_090125.xml","form_type":"4"}},{"id":1664965,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-01-31T16:29:30.000Z","date":"2024-01-29","kind":"exercise","planned":false,"acquired":true,"shares":13750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":178566,"source":{"system":"sec-edgar","filing":"0001415889-24-002072","document":"form4-01312024_090125.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000141588924002072/form4-01312024_090125.xml","form_type":"4"}},{"id":1965364,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2023-03-07T16:56:56.000Z","date":"2023-03-03","kind":"exercise","acquired":false,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs vest as to 1/4th of the total shares annually beginning on March 5, 2022, subject to continued service through each vesting date."}],"balance_after":37500,"derivative":{"expiration_date":"2025-03-05","underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001209191-23-016809","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919123016809/doc4.xml","form_type":"4"}},{"id":1965363,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2023-03-07T16:56:56.000Z","date":"2023-03-03","kind":"exercise","acquired":false,"shares":31125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vest as to 1/4th of the total shares annually beginning on March 4, 2023, subject to continued service through each vesting date."}],"balance_after":93375,"derivative":{"expiration_date":"2026-03-04","underlying":"Common Stock","underlying_shares":31125},"source":{"system":"sec-edgar","filing":"0001209191-23-016809","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919123016809/doc4.xml","form_type":"4"}},{"id":1965362,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2023-03-07T16:56:56.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest as to 1/4th of the total shares annually beginning on March 1, 2024, subject to continued service through each vesting date."}],"balance_after":95000,"derivative":{"expiration_date":"2027-03-01","underlying":"Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0001209191-23-016809","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919123016809/doc4.xml","form_type":"4"}},{"id":1965361,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2023-03-07T16:56:56.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests as to 2.0833% of the total shares monthly, beginning on April 1, 2023, with 100% of the total shares vested and exercisable on March 1, 2027, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":125000,"derivative":{"exercise_price":5.79,"expiration_date":"2033-02-28","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-23-016809","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919123016809/doc4.xml","form_type":"4"}},{"id":1965360,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-03-07T16:56:56.000Z","date":"2023-03-03","kind":"tax_withholding","acquired":false,"shares":17246,"price":5.79,"value":99854.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person."}],"balance_after":164816,"source":{"system":"sec-edgar","filing":"0001209191-23-016809","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919123016809/doc4.xml","form_type":"4"}},{"id":1965359,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-03-07T16:56:56.000Z","date":"2023-03-03","kind":"exercise","acquired":true,"shares":18750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."}],"balance_after":182062,"source":{"system":"sec-edgar","filing":"0001209191-23-016809","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919123016809/doc4.xml","form_type":"4"}},{"id":1965358,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-03-07T16:56:56.000Z","date":"2023-03-03","kind":"exercise","acquired":true,"shares":31125,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."}],"balance_after":163312,"source":{"system":"sec-edgar","filing":"0001209191-23-016809","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919123016809/doc4.xml","form_type":"4"}},{"id":2040070,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2023-01-31T17:31:47.000Z","date":"2023-01-27","kind":"exercise","acquired":false,"shares":13750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest as to 1/4th of the total shares annually beginning on January 29, 2021, subject to continued service through each vesting date."}],"balance_after":13750,"derivative":{"expiration_date":"2024-01-29","underlying":"Common Stock","underlying_shares":13750},"source":{"system":"sec-edgar","filing":"0001209191-23-005765","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919123005765/doc4.xml","form_type":"4"}},{"id":2040069,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-01-31T17:31:47.000Z","date":"2023-01-27","kind":"tax_withholding","acquired":false,"shares":5600,"price":7.5,"value":42000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person."}],"balance_after":132187,"source":{"system":"sec-edgar","filing":"0001209191-23-005765","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919123005765/doc4.xml","form_type":"4"}},{"id":2040068,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-01-31T17:31:47.000Z","date":"2023-01-27","kind":"exercise","acquired":true,"shares":13750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 10,577 shares of common stock transferred from the Newell Family Revocable Trust DTD 08/14/2008."}],"balance_after":137787,"source":{"system":"sec-edgar","filing":"0001209191-23-005765","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919123005765/doc4.xml","form_type":"4"}},{"id":2332954,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-03-15T19:00:39.000Z","date":"2022-03-14","kind":"purchase","acquired":true,"shares":10000,"price":7.7508,"value":77508.0,"ownership":{"direct":false,"nature":"By William J. Newell Family Trust DTD 03/15/2019"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.68 to\n$7.85 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the\nSecurities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within\nthe range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held of record by the reporting person as trustee of the William J. Newell Family Trust DTD 03/15/2019."}],"balance_after":116525,"source":{"system":"sec-edgar","filing":"0001209191-22-018969","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919122018969/doc4.xml","form_type":"4"}},{"id":2347369,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2022-03-07T19:25:58.000Z","date":"2022-03-05","kind":"exercise","acquired":false,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs vest as to 1/4th of the total shares annually beginning on March 5, 2022, subject to continued service through each vesting date."}],"balance_after":56250,"derivative":{"expiration_date":"2025-03-05","underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001209191-22-016856","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919122016856/doc4.xml","form_type":"4"}},{"id":2347368,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2022-03-07T19:25:58.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":124500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vest as to 1/4th of the total shares annually beginning on March 4, 2023, subject to continued service through each vesting date."}],"balance_after":124500,"derivative":{"expiration_date":"2026-03-04","underlying":"Common Stock","underlying_shares":124500},"source":{"system":"sec-edgar","filing":"0001209191-22-016856","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919122016856/doc4.xml","form_type":"4"}},{"id":2347367,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2022-03-07T19:25:58.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":166000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests as to 2.0833% of the total shares monthly, beginning on April 4, 2022, with 100% of the total shares vested and exercisable on March 4, 2026, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":166000,"derivative":{"exercise_price":8.17,"expiration_date":"2032-03-03","underlying":"Common Stock","underlying_shares":166000},"source":{"system":"sec-edgar","filing":"0001209191-22-016856","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919122016856/doc4.xml","form_type":"4"}},{"id":2347366,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-03-07T19:25:58.000Z","date":"2022-03-05","kind":"tax_withholding","acquired":false,"shares":6483,"price":8.17,"value":52966.11,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person."}],"balance_after":113460,"source":{"system":"sec-edgar","filing":"0001209191-22-016856","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919122016856/doc4.xml","form_type":"4"}},{"id":2347365,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-03-07T19:25:58.000Z","date":"2022-03-05","kind":"exercise","acquired":true,"shares":18750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."}],"balance_after":119943,"source":{"system":"sec-edgar","filing":"0001209191-22-016856","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919122016856/doc4.xml","form_type":"4"}},{"id":2418942,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2022-02-01T20:37:54.000Z","date":"2022-01-29","kind":"exercise","acquired":false,"shares":13750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest as to 1/4th of the total shares annually beginning on January 29, 2021, subject to continued service through each vesting date."}],"balance_after":27500,"derivative":{"expiration_date":"2025-01-29","underlying":"Common Stock","underlying_shares":13750},"source":{"system":"sec-edgar","filing":"0001209191-22-006128","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919122006128/doc4.xml","form_type":"4"}},{"id":2418941,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-02-01T20:37:54.000Z","date":"2022-01-29","kind":"tax_withholding","acquired":false,"shares":5278,"price":10.39,"value":54838.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person."}],"balance_after":101193,"source":{"system":"sec-edgar","filing":"0001209191-22-006128","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919122006128/doc4.xml","form_type":"4"}},{"id":2418940,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-02-01T20:37:54.000Z","date":"2022-01-29","kind":"exercise","acquired":true,"shares":13750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":106471,"source":{"system":"sec-edgar","filing":"0001209191-22-006128","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919122006128/doc4.xml","form_type":"4"}},{"id":2453854,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-01-03T18:28:01.000Z","date":"2021-12-30","kind":"other","acquired":true,"shares":1863,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By William J. Newell Family Trust DTD 03/15/2019"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares received as a liquidating distribution from Taluswood."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities are held of record by the reporting person as trustee of the William J. Newell Family Trust DTD 03/15/2019."}],"balance_after":106525,"source":{"system":"sec-edgar","filing":"0001209191-22-000329","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919122000329/doc4.xml","form_type":"4"}},{"id":2453853,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-01-03T18:28:01.000Z","date":"2021-12-30","kind":"other","acquired":false,"shares":26091,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Taluswood Partners, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents pro rata distributions to the limited partners of Taluswood Partners, L.P. (\"Taluswood\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person is the general partner of Taluswood.  The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-000329","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919122000329/doc4.xml","form_type":"4"}},{"id":2557519,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2021-09-28T18:58:03.000Z","date":"2021-09-24","kind":"exercise","acquired":false,"shares":25253,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vest as to 1/3rd of the total shares annually beginning on September 26, 2019, subject to continued service through each vesting date."}],"balance_after":0,"derivative":{"expiration_date":"2021-09-26","underlying":"Common Stock","underlying_shares":25253},"source":{"system":"sec-edgar","filing":"0001209191-21-057981","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919121057981/doc4.xml","form_type":"4"}},{"id":2557518,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-09-28T18:58:03.000Z","date":"2021-09-24","kind":"tax_withholding","acquired":false,"shares":13219,"price":19.23,"value":254201.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person."}],"balance_after":92721,"source":{"system":"sec-edgar","filing":"0001209191-21-057981","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919121057981/doc4.xml","form_type":"4"}},{"id":2557517,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-09-28T18:58:03.000Z","date":"2021-09-24","kind":"exercise","acquired":true,"shares":25253,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":105940,"source":{"system":"sec-edgar","filing":"0001209191-21-057981","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919121057981/doc4.xml","form_type":"4"}},{"id":2557516,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-09-28T18:58:03.000Z","date":"2021-07-01","kind":"gift","acquired":true,"shares":104662,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By William J. Newell Family Trust DTD 03/15/2019"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held of record by the reporting person as trustee of the William J. Newell Family Trust DTD 03/15/2019."}],"balance_after":104662,"source":{"system":"sec-edgar","filing":"0001209191-21-057981","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919121057981/doc4.xml","form_type":"4"}},{"id":2557515,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-09-28T18:58:03.000Z","date":"2021-07-01","kind":"gift","acquired":false,"shares":104662,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":80687,"source":{"system":"sec-edgar","filing":"0001209191-21-057981","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919121057981/doc4.xml","form_type":"4"}},{"id":2802744,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2021-03-08T17:20:59.000Z","date":"2021-03-05","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/4th of the total shares annually beginning on March 5, 2022, subject to continued service through each vesting date."}],"balance_after":75000,"derivative":{"expiration_date":"2025-03-05","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-21-018623","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919121018623/doc4.xml","form_type":"4"}},{"id":2802743,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2021-03-08T17:20:59.000Z","date":"2021-03-05","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 2.0833% of the total shares monthly, beginning on April 5, 2021, with 100% of the total shares vested and exercisable on March 5, 2025, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":200000,"derivative":{"exercise_price":21.11,"expiration_date":"2031-03-04","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-21-018623","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919121018623/doc4.xml","form_type":"4"}},{"id":2888369,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2021-02-01T17:56:48.000Z","date":"2021-01-29","kind":"exercise","acquired":false,"shares":13750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest as to 1/4th of the total shares annually beginning on January 29, 2021, subject to continued service through each vesting date."}],"balance_after":41250,"derivative":{"expiration_date":"2024-01-29","underlying":"Common Stock","underlying_shares":13750},"source":{"system":"sec-edgar","filing":"0001209191-21-006559","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919121006559/doc4.xml","form_type":"4"}},{"id":2888368,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-02-01T17:56:48.000Z","date":"2021-01-29","kind":"tax_withholding","acquired":false,"shares":7061,"price":22.15,"value":156401.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person."}],"balance_after":185349,"source":{"system":"sec-edgar","filing":"0001209191-21-006559","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919121006559/doc4.xml","form_type":"4"}},{"id":2888367,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-02-01T17:56:48.000Z","date":"2021-01-29","kind":"exercise","acquired":true,"shares":13750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":192410,"source":{"system":"sec-edgar","filing":"0001209191-21-006559","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919121006559/doc4.xml","form_type":"4"}},{"id":2950168,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-11T01:39:36.000Z","date":"2020-12-09","kind":"grant","acquired":true,"shares":22228,"price":1.29,"value":28674.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired by the reporting person from Sutro Biopharma, Inc. pursuant to the Sutro Biopharma, Inc. 2017 Call Option Plan."}],"balance_after":66684,"source":{"system":"sec-edgar","filing":"0001209191-20-062813","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919120062813/doc4.xml","form_type":"4"}},{"id":3021606,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2020-09-28T17:57:27.000Z","date":"2020-09-25","kind":"exercise","acquired":false,"shares":25252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest as to 1/3rd of the total shares annually beginning on September 26, 2019, subject to continued service through each vesting date."}],"balance_after":25253,"derivative":{"expiration_date":"2021-09-26","underlying":"Common Stock","underlying_shares":25252},"source":{"system":"sec-edgar","filing":"0001209191-20-052248","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919120052248/doc4.xml","form_type":"4"}},{"id":3021605,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-09-28T17:57:27.000Z","date":"2020-09-25","kind":"tax_withholding","acquired":false,"shares":13219,"price":10.3,"value":136155.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person."}],"balance_after":178660,"source":{"system":"sec-edgar","filing":"0001209191-20-052248","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919120052248/doc4.xml","form_type":"4"}},{"id":3021604,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-09-28T17:57:27.000Z","date":"2020-09-25","kind":"exercise","acquired":true,"shares":25252,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":191879,"source":{"system":"sec-edgar","filing":"0001209191-20-052248","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919120052248/doc4.xml","form_type":"4"}},{"id":3110574,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-15T22:19:33.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3 of the shares subject to the option vest on June 11, 2021, and 1/36 of the shares vest monthly thereafter."}],"balance_after":40000,"derivative":{"exercise_price":16,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-20-036742","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919120036742/doc4.xml","form_type":"4"}},{"id":3148602,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-05-14T17:29:22.000Z","date":"2020-05-14","kind":"purchase","acquired":true,"shares":64516,"price":7.75,"value":499999.0,"ownership":{"direct":true},"balance_after":166627,"source":{"system":"sec-edgar","filing":"0001209191-20-029246","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919120029246/doc4.xml","form_type":"4"}},{"id":3296431,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2020-01-31T17:20:31.000Z","date":"2020-01-29","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vest as to 1/4th of the total shares annually beginning on January 29, 2021, subject to continued service through each vesting date."}],"balance_after":55000,"derivative":{"expiration_date":"2024-01-29","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001209191-20-005814","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919120005814/doc4.xml","form_type":"4"}},{"id":3296430,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2020-01-31T17:20:31.000Z","date":"2020-01-29","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests as to 2.0833% of the total shares monthly, beginning on February 29, 2020, with 100% of the total shares vested and exercisable on January 29, 2024, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":125000,"derivative":{"exercise_price":10.09,"expiration_date":"2030-01-29","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-20-005814","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919120005814/doc4.xml","form_type":"4"}},{"id":3404256,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2019-09-30T17:26:28.000Z","date":"2019-09-26","kind":"exercise","acquired":false,"shares":25252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs vest as to 1/3rd of the total shares annually beginning on September 26, 2019, subject to continued service through each vesting date."}],"balance_after":50505,"derivative":{"expiration_date":"2021-09-26","underlying":"Common Stock","underlying_shares":25252},"source":{"system":"sec-edgar","filing":"0001209191-19-051124","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919119051124/doc4.xml","form_type":"4"}},{"id":3404255,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-09-30T17:26:28.000Z","date":"2019-09-26","kind":"tax_withholding","acquired":false,"shares":13219,"price":9.74,"value":128753.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person."}],"balance_after":106118,"source":{"system":"sec-edgar","filing":"0001209191-19-051124","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919119051124/doc4.xml","form_type":"4"}},{"id":3404254,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-09-30T17:26:28.000Z","date":"2019-09-26","kind":"exercise","acquired":true,"shares":25252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Since the date of the reporting person's last ownership report, he transferred 94,085 shares of the issuer's common stock in a transfer exempt from Section 16. Following this transfer, the reporting person does not have voting or investment power over, or a pecuniary interest in, the transferred shares."}],"balance_after":119337,"source":{"system":"sec-edgar","filing":"0001209191-19-051124","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919119051124/doc4.xml","form_type":"4"}},{"id":3681077,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2019-01-31T17:11:10.000Z","date":"2019-01-29","kind":"grant","acquired":true,"shares":445000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 2.0833% of the total shares monthly, beginning on February 28, 2019, with 100% of the total shares vested and exercisable on January 29, 2023, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":445000,"derivative":{"exercise_price":10.45,"expiration_date":"2029-01-28","underlying":"Common Stock","underlying_shares":445000},"source":{"system":"sec-edgar","filing":"0001209191-19-006206","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919119006206/doc4.xml","form_type":"4"}},{"id":3804062,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Series B Preferred Stock","published_at":"2018-10-01T17:20:50.000Z","date":"2018-10-01","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Newell Family Revocable Trust DTD 08/14/2008"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of the issuer's Series B Preferred Stock automatically converted into 0.0578 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of the issuer's Series B Preferred Stock automatically converted into 0.0578 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of the issuer's Series B Preferred Stock automatically converted into 0.0578 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are held of record by the reporting person as trustee of the Newell Family Revocable Trust DTD 08/14/2008."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2890},"source":{"system":"sec-edgar","filing":"0001209191-18-052841","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919118052841/doc4.xml","form_type":"4"}},{"id":3804061,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Series D Preferred Stock","published_at":"2018-10-01T17:20:50.000Z","date":"2018-10-01","kind":"exercise","acquired":false,"shares":192267,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of the issuer's Series D Preferred Stock automatically converted into 0.0405 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of the issuer's Series D Preferred Stock automatically converted into 0.0405 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of the issuer's Series D Preferred Stock automatically converted into 0.0405 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7787},"source":{"system":"sec-edgar","filing":"0001209191-18-052841","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919118052841/doc4.xml","form_type":"4"}},{"id":3804060,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Series C Preferred Stock","published_at":"2018-10-01T17:20:50.000Z","date":"2018-10-01","kind":"exercise","acquired":false,"shares":55657,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the issuer's Series C Preferred Stock automatically converted into 0.0370 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its firm commitment initial public offering (the \"IPO\") pursuant to a registration statement on Form S-1 (File No. 333-227103) under the Securities Act of 1933, as amended (the \"Registration Statement\"), and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the issuer's Series C Preferred Stock automatically converted into 0.0370 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its firm commitment initial public offering (the \"IPO\") pursuant to a registration statement on Form S-1 (File No. 333-227103) under the Securities Act of 1933, as amended (the \"Registration Statement\"), and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the issuer's Series C Preferred Stock automatically converted into 0.0370 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its firm commitment initial public offering (the \"IPO\") pursuant to a registration statement on Form S-1 (File No. 333-227103) under the Securities Act of 1933, as amended (the \"Registration Statement\"), and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2059},"source":{"system":"sec-edgar","filing":"0001209191-18-052841","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919118052841/doc4.xml","form_type":"4"}},{"id":3804059,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2018-10-01T17:20:50.000Z","date":"2018-10-01","kind":"exercise","acquired":true,"shares":2890,"ownership":{"direct":false,"nature":"By Newell Family Revocable Trust DTD 08/14/2008"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of the issuer's Series B Preferred Stock automatically converted into 0.0578 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are held of record by the reporting person as trustee of the Newell Family Revocable Trust DTD 08/14/2008."}],"balance_after":21154,"source":{"system":"sec-edgar","filing":"0001209191-18-052841","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919118052841/doc4.xml","form_type":"4"}},{"id":3804058,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2018-10-01T17:20:50.000Z","date":"2018-10-01","kind":"exercise","acquired":true,"shares":7787,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of the issuer's Series D Preferred Stock automatically converted into 0.0405 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date."}],"balance_after":188170,"source":{"system":"sec-edgar","filing":"0001209191-18-052841","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919118052841/doc4.xml","form_type":"4"}},{"id":3804057,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2018-10-01T17:20:50.000Z","date":"2018-10-01","kind":"exercise","acquired":true,"shares":2059,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the issuer's Series C Preferred Stock automatically converted into 0.0370 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its firm commitment initial public offering (the \"IPO\") pursuant to a registration statement on Form S-1 (File No. 333-227103) under the Securities Act of 1933, as amended (the \"Registration Statement\"), and had no expiration date."}],"balance_after":180383,"source":{"system":"sec-edgar","filing":"0001209191-18-052841","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919118052841/doc4.xml","form_type":"4"}},{"id":3806457,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2018-09-27T18:03:54.000Z","date":"2018-09-26","kind":"grant","acquired":true,"shares":75757,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/3rd of the total shares annually beginning on September 26, 2019, subject to continued service through each vesting date."}],"balance_after":75757,"derivative":{"expiration_date":"2021-09-25","underlying":"Common Stock","underlying_shares":75757},"source":{"system":"sec-edgar","filing":"0001209191-18-052492","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919118052492/doc4.xml","form_type":"4"}},{"id":3806456,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":82236,"kind":"person","name":"NEWELL WILLIAM J","position":1,"cik":"0001309660","reported_name":"NEWELL WILLIAM J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2018-09-27T18:03:54.000Z","date":"2018-09-26","kind":"grant","acquired":true,"shares":454545,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 2.0833% of the total shares monthly, beginning on October 26, 2018, with 100% of the total shares vested and exercisable on September 26, 2022, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":454545,"derivative":{"exercise_price":15,"expiration_date":"2028-09-25","underlying":"Common Stock","underlying_shares":454545},"source":{"system":"sec-edgar","filing":"0001209191-18-052492","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309660/000120919118052492/doc4.xml","form_type":"4"}}]}